Skip to main content
. Author manuscript; available in PMC: 2019 Oct 15.
Published in final edited form as: Vaccine. 2018 Sep 14;36(43):6424–6432. doi: 10.1016/j.vaccine.2018.08.032

Fig. 2.

Fig. 2.

Reverse cumulative distributions of hemagglutination inhibition antibody titers for WHO-recommended influenza strains contained in trivalent study vaccines among participants of all ages who were seronegative at baseline for the particular strain. Note: x axis is the HI titer by vaccine and antigen, and the y axis is the percentage of vaccine recipients achieving the measured HI titer.